Nasacort

   
Google
 
Web NewDrugInformation.com

Nasacort


Drug - Nasacort
The trade name of the product as shown on the labeling.

Dosage - AEROSOL, METERED; NASAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Triamcinolone Acetonide
Multiple ingredients are in alphabetical order.

Strength - 0.055MG/INH
The potency of the active ingredient(s), Triamcinolone Acetonide. May repeat for multiple part products.

Applicant - AVENTIS
The firm name holding legal responsibility for Nasacort. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019798
The FDA assigned number to Nasacort. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nasacort. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 11, 1991
The date Nasacort was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Nasacort. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Nasacort is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceutical Products Inc
The full name of the firm holding legal responsibility for the new application of Nasacort.

Nasacort